GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Implantica AG (OSTO:IMP A SDB) » Definitions » Debt-to-Equity

Implantica AG (OSTO:IMP A SDB) Debt-to-Equity : 0.00 (As of . 20)


View and export this data going back to 2020. Start your Free Trial

What is Implantica AG Debt-to-Equity?

Implantica AG's Short-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was kr0.00 Mil. Implantica AG's Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was kr0.00 Mil. Implantica AG's Total Stockholders Equity for the quarter that ended in . 20 was kr0.00 Mil.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Implantica AG's Debt-to-Equity or its related term are showing as below:

OSTO:IMP A SDB's Debt-to-Equity is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 0.21
* Ranked among companies with meaningful Debt-to-Equity only.

Implantica AG Debt-to-Equity Historical Data

The historical data trend for Implantica AG's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Implantica AG Debt-to-Equity Chart

Implantica AG Annual Data
Trend
Debt-to-Equity

Implantica AG Semi-Annual Data
Debt-to-Equity

Competitive Comparison of Implantica AG's Debt-to-Equity

For the Medical Devices subindustry, Implantica AG's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Implantica AG's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Implantica AG's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Implantica AG's Debt-to-Equity falls into.



Implantica AG Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Implantica AG's Debt to Equity Ratio for the fiscal year that ended in . 20 is calculated as

Implantica AG's Debt to Equity Ratio for the quarter that ended in . 20 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Implantica AG  (OSTO:IMP A SDB) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Implantica AG Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Implantica AG's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Implantica AG Business Description

Comparable Companies
Traded in Other Exchanges
Address
Aeulestrasse 45, Vaduz, LIE, 9490
Implantica AG is a medtech group providing effective care for serious health conditions and improving patients' quality of life by bringing advanced technology into the body. The therapies Implantica develops are based on implants that are medical devices inserted into the patient's body and are intended to remain in place permanently or semi-permanently, using electrical power provided by a battery. The company has developed a broad, patent-protected, product pipeline based partly on its two platform technologies. To bring advanced technology into the body, and adequate energy supply is required which would require very large batteries, so, Implantica has developed a wireless energising platform to supply energy to the body through intact skin.

Implantica AG Headlines

No Headlines